Developing immune therapies specifically for dogs

DEVELOPMENT OF CANINE IMMUNOTHERAPY TARGETED AGENTS

NIH-funded research Leidos Biomedical Research, INC. · NIH-10502671

This study is working on new immune treatments for dogs by developing special antibodies to help them feel better, and pet owners might get a chance to help test these promising therapies for their furry friends.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionLeidos Biomedical Research, INC. NIH-funded
Lab location1 site (Frederick, United States)
Project IDNIH-10502671 on NIH RePORTER

What this research studies

This research focuses on creating specialized immune therapies for dogs, particularly targeting the development and production of canine-specific antibodies. By utilizing agonists and antagonists, the study aims to enhance immunotherapy options for companion canines suffering from various conditions. The approach involves rigorous testing and production processes to ensure these therapies are effective and safe for canine patients. Pet owners may have the opportunity to participate in trials that could lead to innovative treatments for their dogs.

Who could benefit from this research

Good fit: Ideal candidates for this research are dogs diagnosed with cancer or other immune-mediated diseases.

Not a fit: Dogs without cancer or immune-related conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could provide new, effective immunotherapy options for dogs with cancer and other immune-related conditions.

How similar studies have performed: While canine immunotherapy is an emerging field, there have been promising results in similar studies focusing on immune therapies for pets.

Where this research is happening

Frederick, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.